Keyphrases
Papillary Thyroid Carcinoma
92%
Diffuse Large B-cell Lymphoma (DLBCL)
67%
BRAF V600E
65%
Immunohistochemistry
57%
Tumor
53%
Indonesian
52%
Indonesia
46%
Bone Marrow
42%
Pancytopenia
36%
BRAF V600E mutation
36%
Morphological Characteristics
34%
Malignancy
33%
Thyroid Carcinoma
33%
Lymphoma
31%
Pathologist
30%
Histological Subtypes
30%
Tumor Cells
29%
Germinal Center B Cells
27%
Fibrosis
27%
General Hospital
27%
Bone Marrow Biopsy
26%
Nuclear Features
25%
Histopathological Features
25%
Complete Remission
24%
RAS-like
23%
Lymph Node Metastasis
23%
Histopathological Examination
23%
Adrenocortical Adenoma
22%
Metaplasia
22%
Hürthle Cell Carcinoma
22%
Cell Carcinoma
22%
Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
22%
Referral Hospital
22%
Pheochromocytoma
22%
Hodgkin Lymphoma
22%
CD-8
22%
Chronic Myeloid Leukemia
22%
Classical Hodgkin Lymphoma
22%
Diagnostic Challenge
22%
BCR-ABL1
22%
Young Female
22%
R-CHOP
21%
Immunohistochemical Staining
21%
Adrenal Mass
19%
Young Males
19%
B Cells
18%
Thyroid Cancer
17%
Breast
16%
Anatomical Pathology
16%
Jakarta
16%
Medicine and Dentistry
Neoplasm
100%
Papillary Thyroid Cancer
98%
Diffuse Large B-Cell Lymphoma
70%
Immunohistochemistry
67%
Carcinoma Cell
44%
B Cell
42%
Bone Marrow Biopsy
38%
Pancytopenia
36%
Fibrosis
36%
Cancer
35%
Pathologist
35%
Thyroid Carcinoma
35%
T-Cell Lymphoma
34%
Tumor Cell
32%
Germinal Center
29%
Morphology
28%
Thyroid Tumor
27%
Lymph Node Metastasis
25%
Haematoxylin
23%
Patient Referral
23%
Splenomegaly
23%
Adrenal Adenoma
22%
Metaplasia
22%
Pheochromocytoma
22%
CD8 Antigen
22%
Classical Hodgkin Lymphoma
22%
Chronic Myelogenous Leukemia
22%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
20%
Eosin
20%
Lymphadenopathy
19%
Lymph Node
19%
Neck
19%
Diseases
18%
Fine-Needle Aspiration
17%
Non-Hodgkin Lymphoma
16%
Megakaryocyte
15%
Differential Diagnosis
15%
Prognostic Factor
15%
Histopathology
14%
Myeloid metaplasia
14%
Multiple Myeloma
14%
Pseudoinclusion
14%
Protein Expression
14%
Rituximab
13%
Retrospective Study
13%
CD3 Antigen
13%
Physical Examination
13%
Adrenalectomy
13%
Nodular Sclerosis Hodgkin Lymphoma
13%
Pediatrics
13%